🔴 Intravenous Infusions is trading 9.09% down today after continued profit-taking following its speculative July 30 rally

Intravenous Infusions is trading at GHS 0.40, down -9.09%, as profit-taking continues after its speculative July 30 rally to GHS 0.86.

• Selling persisted across consecutive sessions, with the stock declining from GHS 0.78 on August 3 to GHS 0.40 by August 12.
• No new major company announcement was identified for August 17, 2026.
• Broader markets were mixed, limiting evidence of a global catalyst.